A novel combination of triple metachronous malignancies of the kidney, oropharynx and prostate: A case report

Pastore, Antonio Luigi; Palleschi, Giovanni; Leto, Andrea; Silvestri, Luigi; Porta, Natale; Petrozza, Vincenzo; Carbone, Antonio

doi:10.3892/ol.2015.3312

Cited by 6 publications

(3 citation statements)

References 13 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Solid tumors comprised 90% of all second malignancies in RCC patients, with the most common second cancers reported in the prostate gland and the digestive and respiratory systems. As shown in Table 1 , in recent years, only five synchronous primary PRAD cases have been reported in RCC patients, with an average age of 68 [ 8 , 9 , 10 , 11 , 12 ]. Most cases (three cases) were diagnosed as RCC of Furhman grade II and PRAD of Gleason score more than 6.…”

Section: ⧉ Discussionmentioning

confidence: 99%

Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review

Ying

Wan

et al. 2020

Rom J Morphol Embryol

View full text Add to dashboard Cite

The objective of this study was to report the diagnosis and treatment results of primary prostate adenocarcinoma (PRAD) concurrent in a patient with renal cell carcinoma (RCC), and to review the relative literature. A 62-year-old man was admitted to our hospital with chief complaint of a painless, incidentally found renal mass for one year. RCC was initially found by computed tomography (CT) scan, but prostate cancer was incidentally found by abnormal prostate-specific antigen (PSA) level results. The post-nephrectomy pathology assay reported clear RCC with positive staining of vimentin, cluster of differentiation 10 (CD10), carbonic anhydrase IX (CA-IX), paired box 8 (Pax-8), epithelial membrane antigen (EMA), and Ki67 labeling index (Ki67 LI). Magnetic resonance imaging (MRI) revealed uneven signals in the right peripheral zone of the prostate. Both prostate biopsy and post-prostatectomy pathology examination revealed prostate acinar adenocarcinoma with positive staining of P504S and Ki67 LI. The patient has been in periodic follow-up and has remained in good general condition without any evidence of recurrence to date. To the best of our knowledge, the present report is the only case of systematically described pre-and post-therapy laboratory, pathology, and imaging examination results. Our report together with published studies suggest that increased awareness of synchronous PRAD risk will enable early detection and prompt therapies in patients with RCC.

show abstract

Section: ⧉ Discussionmentioning

confidence: 99%

Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review

Ying

Wan

et al. 2020

Rom J Morphol Embryol

View full text Add to dashboard Cite

show abstract

“…This may lead to the development of MPM at some point during the lifetime [ 19 – 22 ]. Multiple metachronous malignancies are frequently detected in hematological, lung, thyroid, breast, skin, and genitourinary malignancies [ 23 , 24 ]. Liu et al investigated the etiological factors, clinical characteristics, diagnosis, treatment strategies, and prognosis of MPM and demonstrated that curative surgery has a strong impact on long-term prognosis [ 22 ].…”

Section: Discussionmentioning

confidence: 99%

Metachronous triple cancer associated with Peutz–Jeghers syndrome treated with curative surgery: a case report

et al. 2018

View full text Add to dashboard Cite

BackgroundPeutz–Jeghers syndrome (PJS) is an autosomal dominant disorder characterized by mucocutaneous pigmentation and hamartomatous gastrointestinal polyposis. It is well known that individuals with PJS are at an increased risk of cancer in a variety of organs.Case presentationHere, we present a patient with PJS who achieved long-term survival by undergoing repeat curative surgery for metachronous triple cancer. Her medical history included hilar cholangiocarcinoma and cervical carcinoma; curative surgery was performed for both conditions. On annual follow-up, the level of carcinoembryonic antigen was elevated at 6.9 ng/ml. Enhanced computed tomography revealed a cystic tumor consisting of mural nodules at the pancreatic head; the maximal diameter was 15 mm. Magnetic resonance imaging clearly demonstrated the tumor with low intensity on T1-weighted images and high intensity on T2-weighted images. Endoscopic ultrasound sonography showed a high echoic tumor at the pancreatic head, which was confirmed as adenocarcinoma by fine-needle aspiration biopsy. The preoperative diagnosis was intraductal papillary mucinous carcinoma (IPMC; T1N0M0, stage IA). Subtotal stomach-preserving pancreaticoduodenectomy was performed and the final diagnosis was IPMC, stage 0 (TisN0M0).ConclusionsAggressive surgery for metachronous triple cancer resulted in good long-term prognosis. Continuous and systematic follow-up would allow the detection of malignancy at an early stage and make treatment with curative surgery possible.

show abstract

“…Conversely, as PRC is asymptomatic in the early stages ( 47 ) and is an internal disease, it is frequently incidentally detected. In order to confirm the diagnosis method of PRC of those patients, the cases in Table I were further reviewed and the manner in which the subsequent PRC was detected is indicated ( 28 , 29 , 31 , 33 – 35 , 37 , 38 ) ( Table II ). Of the 9 patients in which PRC was diagnosed, including the present case, PRC was detected by a serum test in 2, incidentally by surgery of the other tumor in 2, by FDG-PET in 2 and by clinical symptoms in 1 (PRC detection in 2 patients was not described).…”

Section: Discussionmentioning

confidence: 99%

Triple primary cancer of the head and neck, skin and prostate: A case report and literature review

et al. 2018

View full text Add to dashboard Cite

Second primary cancer (SPC) is an important prognostic factor for patients with head and neck cancer (HNC); therefore, the association between the prognosis and development of SPC has been well-reported. The use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) is valuable to examine cancer stage, evaluate treatment responses and investigate suspected relapses or metastases. In the present study, the case of a male patient who was diagnosed with three primary cancer types, including well to moderately differentiated squamous cell carcinoma (SCC) of the mandible, axillary cutaneous poorly differentiated SCC and prostate adenocarcinoma, was described. Among these, mandible cancer was the first diagnosed when the patient was 70 years of age. Synchronous skin and prostate cancer (PRC) types then developed 3 years later. To the best of our knowledge, this is the first report of the aforementioned combination of cancer types. Postoperative FDG-PET was not performed as no lesions of recurrence or metastases of mandible cancer were found. Three years later, the PRC was asymptomatic and was incidentally detected by FDG-PET performed for a preoperative evaluation of skin cancer. It was indicated that FDG-PET could be utilized in patients with HNC due to there being no accurate FDG-PET protocol to detect SPC over a long-term follow-up.

show abstract

A novel combination of triple metachronous malignancies of the kidney, oropharynx and prostate: A case report

Cited by 6 publications

References 13 publications

Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review

Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review

Metachronous triple cancer associated with Peutz–Jeghers syndrome treated with curative surgery: a case report

Triple primary cancer of the head and neck, skin and prostate: A case report and literature review

Contact Info

Product

Resources

About